228 related articles for article (PubMed ID: 10772998)
1. Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: focus on DP class prostanoids.
Sharif NA; Crider JY; Xu SX; Williams GW
J Pharmacol Exp Ther; 2000 May; 293(2):321-8. PubMed ID: 10772998
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the platelet prostaglandin D2 receptor. Loss of prostaglandin D2 receptors in platelets of patients with myeloproliferative disorders.
Cooper B; Ahern D
J Clin Invest; 1979 Aug; 64(2):586-90. PubMed ID: 222813
[TBL] [Abstract][Full Text] [Related]
3. Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes.
Sharif NA; Williams GW; Crider JY; Xu SX; Davis TL
J Ocul Pharmacol Ther; 2004 Dec; 20(6):489-508. PubMed ID: 15684809
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: pharmacological characterization using agonists and antagonists.
Crider JY; Griffin BW; Sharif NA
Br J Pharmacol; 1999 May; 127(1):204-10. PubMed ID: 10369474
[TBL] [Abstract][Full Text] [Related]
5. Ocular hypotensive DP-class prostaglandin receptor affinities determined by quantitative autoradiography on human eye sections.
Sharif NA; Davis TL; Williams GW
J Ocul Pharmacol Ther; 2005 Apr; 21(2):121-32. PubMed ID: 15857278
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology and autoradiography of human DP prostanoid receptors using [(3)H]-BWA868C, a DP receptor-selective antagonist radioligand.
Sharif NA; Williams GW; Davis TL
Br J Pharmacol; 2000 Nov; 131(6):1025-38. PubMed ID: 11082108
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of [(3)H]-prostaglandin E(2) binding to the cloned human EP(4) prostanoid receptor.
Davis TL; Sharif NA
Br J Pharmacol; 2000 Aug; 130(8):1919-26. PubMed ID: 10952683
[TBL] [Abstract][Full Text] [Related]
8. Exogenous but not endogenous prostanoids regulate cytokine secretion from murine bone marrow dendritic cells: EP2, DP, and IP but not EP1, EP3, and FP prostanoid receptors are involved.
Józefowski S; Bobek M; Marcinkiewicz J
Int Immunopharmacol; 2003 Jun; 3(6):865-78. PubMed ID: 12781703
[TBL] [Abstract][Full Text] [Related]
9. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
[TBL] [Abstract][Full Text] [Related]
10. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
Ashby B
Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
[TBL] [Abstract][Full Text] [Related]
11. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells.
Kiriyama M; Ushikubi F; Kobayashi T; Hirata M; Sugimoto Y; Narumiya S
Br J Pharmacol; 1997 Sep; 122(2):217-24. PubMed ID: 9313928
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data.
Sharif NA; Xu SX; Williams GW; Crider JY; Griffin BW; Davis TL
J Pharmacol Exp Ther; 1998 Aug; 286(2):1094-102. PubMed ID: 9694973
[TBL] [Abstract][Full Text] [Related]
13. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
14. Identification of prostanoid receptors in rabbit non-pigmented ciliary epithelial cells.
Bhattacherjee P; Jacobs N; Coca-Prados M; Paterson C
Exp Eye Res; 1996 May; 62(5):491-8. PubMed ID: 8759517
[TBL] [Abstract][Full Text] [Related]
15. Central prostaglandin D(2) exhibits anxiolytic-like activity via the DP(1) receptor in mice.
Zhao H; Ohinata K; Yoshikawa M
Prostaglandins Other Lipid Mediat; 2009 Apr; 88(3-4):68-72. PubMed ID: 19007903
[TBL] [Abstract][Full Text] [Related]
16. Effects of prostaglandin D(2) and 5-lipoxygenase products on the expression of CD203c and CD11b by basophils.
Monneret G; Boumiza R; Gravel S; Cossette C; Bienvenu J; Rokach J; Powell WS
J Pharmacol Exp Ther; 2005 Feb; 312(2):627-34. PubMed ID: 15388786
[TBL] [Abstract][Full Text] [Related]
17. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
[TBL] [Abstract][Full Text] [Related]
18. AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor.
Griffin BW; Klimko P; Crider JY; Sharif NA
J Pharmacol Exp Ther; 1999 Sep; 290(3):1278-84. PubMed ID: 10454504
[TBL] [Abstract][Full Text] [Related]
19. Intraocular pressure effects of selective prostanoid receptor agonists involve different receptor subtypes according to radioligand binding studies.
Woodward DF; Lawrence RA; Fairbairn CE; Shan T; Williams LS
J Lipid Mediat; 1993; 6(1-3):545-53. PubMed ID: 8358015
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist.
Wright DH; Metters KM; Abramovitz M; Ford-Hutchinson AW
Br J Pharmacol; 1998 Apr; 123(7):1317-24. PubMed ID: 9579725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
